Holdsworth, M T <br/><br/>
Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).  [electronic resource] 

 -  Biotechnology therapeutics  1993 
 - 183-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0898-2848 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Escherichia coli<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--complications<br/>Neutropenia--chemically induced<br/>Recombinant Proteins--administration & dosage<br/>Yeasts